Perspective Therapeutics, Inc.

US$0.84As of Sun 8 Nov 2026, 12:00 UTC
AMEX:CATXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (17.83%)
Div yield —
ROE (39.57%)
Medical Devices
Beta (5Y) 1.99
PE TTM —
TSR TTM (69.23%)
Mkt cap US$95.89M
ROIC (26.22%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.02
20.90%
(74.34%)
Sell 5|1|1|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
7.32%
2.88%
(3.84%)
2.33%
Revenue$M
6.074
6.053
6.193
6.260
(2.22%)
(0.03%)
5.23%
3.90%
Peers (US$95.89M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.781
3.377
2.944
EBIT/Intx
0.797
0.157
0.134
Own earn%
36.03
(138.15)
(109.05)
Sh yield%
49.28
51.15
49.18
Owners
Insiders/Inst%
7.76
31.06
Short interest%
2.59
SBC / revenue%
1.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
15–23
$1 testx
—
Incr. ROIC%
2